KENNEDY CAPITAL MANAGEMENT LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 175 filers reported holding HAEMONETICS CORP in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
KENNEDY CAPITAL MANAGEMENT LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2014$2,117,000
-76.0%
60,635
-75.8%
0.04%
-74.4%
Q2 2014$8,825,000
-0.4%
250,141
-8.0%
0.16%
-1.8%
Q1 2014$8,862,000
-24.2%
271,919
-2.0%
0.17%
-22.7%
Q4 2013$11,684,000
-8.9%
277,335
-13.7%
0.22%
-12.9%
Q3 2013$12,820,000
-7.0%
321,458
-3.6%
0.25%
-11.4%
Q2 2013$13,787,000333,4110.28%
Other shareholders
HAEMONETICS CORP shareholders Q2 2014
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders